Connect Biopharma
(NASDAQ) CNTB
Connect Biopharma Financials at a Glance
Market Cap
$139.61M
Revenue (TTM)
$24.86M
Net Income (TTM)
$22.07M
EPS (TTM)
$-1.00
P/E Ratio
-2.48
Dividend
$0.00
Beta (Volatility)
0.49 (Low)
Dividend
$0.00
Beta (Volatility)
0.49 (Low)
Price
$2.44
Volume
100
Open
$2.44
Price
$2.44
Volume
100
Open
$2.44
Previous Close
$2.47
Daily Range
$2.44 - $2.44
52-Week Range
$0.70 - $3.82
Dividend
$0.00
Beta (Volatility)
0.49 (Low)
Price
$2.44
Volume
100
Open
$2.44
Previous Close
$2.47
Daily Range
$2.44 - $2.44
52-Week Range
$0.70 - $3.82
CNTB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Connect Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
64
CEO
Barry D. Quart, PharmD
Website
www.connectbiopharm.comHeadquarters
Taicang, 215400, CN
CNTB Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-603%
Net Income Margin
-584%
Return on Equity
0%
Return on Capital
-68%
Return on Assets
-50%
Earnings Yield
-40.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$139.61M
Shares Outstanding
56.52M
Volume
100
Avg. Volume
247.08K
Financials (TTM)
Gross Profit
$64.00K
Operating Income
$58.07M
EBITDA
$57.37M
Operating Cash Flow
$51.21M
Capital Expenditure
$434.00K
Free Cash Flow
$51.64M
Cash & ST Invst.
$44.34M
Total Debt
$690.00K
Connect Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$139.61M
N/A
Market Cap/Employee
$2.25M
N/A
Employees
62
N/A
Net Income
$15.11M
+52.2%
EBITDA
$15.35M
+56.6%
Quarterly Fundamentals
Net Cash
$43.65M
-63.0%
Accounts Receivable
$161.00K
-54.1%
Inventory
$0.00
N/A
Long Term Debt
$368.00K
+104.4%
Short Term Debt
$322.00K
+13.0%
Return on Assets
-49.95%
N/A
Return on Invested Capital
-68.18%
N/A
Free Cash Flow
$38.75M
-129.9%
Operating Cash Flow
$38.62M
-129.3%